Anavex Life Sciences Corp...

NASDAQ: AVXL · Real-Time Price · USD
9.68
0.24 (2.54%)
At close: Aug 20, 2025, 3:59 PM
9.71
0.31%
After-hours: Aug 20, 2025, 06:57 PM EDT

Anavex Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-43M -47.51M -47.98M -37.91M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
9.44M 16.37M 18.38M 8.23M
Other Working Capital
-2.81M 1.52M 331K 2.83M
Other Non-Cash Items
n/a 845K 242.00 403.00
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.75M 2.5M 5.36M -706.44K
Operating Cash Flow
-30.81M -27.79M -24.24M -30.38M
Capital Expenditures
n/a n/a 4.00 4.00
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
691K 1.78M n/a 23.4K
Financial Cash Flow
11.97M 29.65M 21.29M 153.24M
Net Cash Flow
-18.84M 1.87M -2.95M 122.86M
Free Cash Flow
-30.81M -27.79M -24.24M -30.38M